ARBACEIangiotensin-converting enzyme inhibitorsAlzheimer’s diseaseAD
… pathology (AOR 0.27 (95% CI 0.21 to 0.36), p<0.001).Conclusion ARB use is associated with a lower risk of AD pathology. The associ…
Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
… pathology (AOR 0.27 (95% CI 0.21 to 0.36), p<0.001).Conclusion ARB use is associated with a lower risk of AD pathology. The associ…
…e therapy at discharge in 2022. Prescription rates for ACEi/ARB/ARNI (67%), beta-blockers (89%), MRAs (40%), and SGLT2 inhibitors (4…